INTERNATIONAL PATENT: ROSWELL PARK CANCER INSTITUTE CORPORATION FILES APPLICATION FOR "TARGETING IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT BY BLOCKING NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) IN MYELOID CELLS"

GENEVA, Dec. 24 -- ROSWELL PARK CANCER INSTITUTE CORPORATION (Elm and Carlton StreetsBuffalo, New York 14263) filed a patent application (PCT/US2025/033473) for "TARGETING IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT BY BLOCKING NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) IN MYELOID CELLS" on Jun 13, 2025. With publication no. WO/2025/259942, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOHAMMADPOUR, Hemn (112 Patrice TerraceWilliamsville, New York 14221), YAN, Qi (56 Shade Tree Ct.Williamsville, New York 14221), HILLEN...